Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.69 |
| ▸ | NPY2R | P49146 | 7/20 | 0.64 |
| ▸ | NPY4R | P50391 | 7/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.64 |
| ▸ | NPY1R | P25929 | 5/20 | 0.64 |
| ▸ | TFPI | P10646 | 4/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29624204 | 0.95 | CALCR (0.76) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29413135 | 0.95 | CALCR (0.76) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29523674 | 0.94 | CALCR (0.70) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182744 | 0.94 | NPY2R (0.67) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30578733 | 0.92 | CALCR (0.73) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30578729 | 0.92 | CALCR (0.73) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30578734 | 0.92 | CALCR (0.73) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182566 | 0.92 | TFPI (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30432168 | 0.92 | NPY2R (0.65) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182900 | 0.91 | CALCR (0.67) | CALCRNPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | CALCR 1215/4885NPY2R 577/4885NPY4R 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.